Nanosonics Limited NAN
ASX · Australia · Health Technology
AUD 2.88+0.00 (+0.17%)
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Nanosonics Ltd (NNCSF) reports 6% constant currency revenue growth and 21% EBIT increase, while unveiling a $40 million buyback and preparing for the commercial launch of its CORIS platform.
As Australian shares prepare for a modest rise, the local market is closely watching economic indicators such as job advertisements and building approvals, alongside international developments like U.S.-Iran peace talks. For investors considering smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing area of investment. These stocks can offer surprising value and growth potential when backed by strong financials, making them worth considering for...
As the Australian market experiences fluctuations driven by global events and economic shifts, investors are keeping a close eye on growth companies that have demonstrated resilience and potential. In this environment, stocks with high insider ownership often attract attention, as they suggest a strong alignment between company leaders and shareholder interests—a crucial factor when navigating uncertain markets.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.